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Normal vascular development in the mouse retina depends on hypoxia-inducible 
factor 2a expression in neuroprogenitor cells. 
 
Abstract:  
In the adult central nervous system, endothelial and neuronal cells engage in tight 
cross-talk as key components of the so-called neurovascular unit. Impairment of their 
critical relationship adversely affects tissue homeostasis, as observed in 
neurodegenerative conditions including Alzheimer’s and Parkinson’s disease. In 
development, the influence of neuroprogenitor cells on angiogenesis is poorly 
understood. Here, we show that these cells interact intimately with the growing 
retinal vascular network, and we identify a novel regulatory mechanism of 
vasculature development mediated by hypoxia-inducible factor 2a (Hif2a). By Cre-lox 
gene excision, we show that Hif2a in retinal neuroprogenitor cells upregulates the 
expression of the pro-angiogenic mediators vascular endothelial growth factor and 
erythropoietin, whereas it locally downregulates the angiogenesis inhibitor 
endostatin. Importantly, absence of Hif2a in retinal neuroprogenitor cells causes a 
marked reduction of proliferating endothelial cells at the angiogenic front. This results 
in delayed retinal vascular development, fewer major retinal vessels and reduced 
density of the peripheral deep retinal vascular plexus. Our findings demonstrate that 
























Oxygen is fundamental for the development, specialization and survival of 
multicellular organisms (Giaccia et al., 2004). In particular, the central nervous 
system (CNS) is highly dependent on oxygen homeostasis for normal function and 
extremely vulnerable to harm from hypoxic injury. Molecular oxygen sensing 
mechanisms have evolved to mediate adaptive responses, including the 
development of new vasculature to meet the oxygen demand of developing tissues 
(Barneo et al., 2001; Giaccia et al., 2004). The main molecular pathway responsible 
for this is controlled by the basic helix-loop-helix transcription elements known as 
hypoxia-inducible factors (HIFs). These are heterodimers formed by an oxygen-
independent β-subunit and an oxygen-dependent α-subunit, of which three variants 
exists: HIF1a, HIF2a (also known as EPAS1) and HIF3a (Hu et al., 2003). Hypoxic 
stabilization of the α-subunit enables dimerization with the β-subunit and binding of 
the dimer to specific sequences on gene promoters (HREs; hypoxia responsive 
elements) to regulate transcription and trigger responses to hypoxia including 
metabolic adaptation, erythropoiesis (via erythropoietin synthesis; EPO) and 
angiogenesis through mediators such as vascular-endothelial growth factor (VEGF) 
(Majmundar et al., 2010).  
In the CNS, neurons (alongside glia) act as oxygen and nutrients sensors, as well as 
vascular regulators, by interacting structurally and functionally with blood vessels in 
the neurovascular unit, impairment of which plays a role in a number of neurological 
conditions (Hawkins and Davis, 2005). In development, neuronal networking and 
vascular formation go hand-in-hand, sharing common molecular cues to ensure that 
developing neuronal networks are supported by an appropriate vascular supply 
(Segura et al., 2009). The laminar development of the neuroretina and its supporting 
vasculature offers a valuable example and model system, in which glial and 
neuroretinal cells mediate a coordinated response to address increasing metabolic 
demand by sensing local availability of oxygen and nutrients (Fruttiger, 2007). In the 
mouse, astrocytes direct the formation of the superficial vascular plexus between 
post-natal day 1 (P1) and P8, both via Hif-dependent (Duan et al., 2014) and Hif-
independent mechanisms (Scott et al., 2010; Weidemann et al., 2010). The 
metabolic demand generated in the outer plexiform layer (OPL) triggers the descent 





















formation reaches completion and maturation by P18 with the development of the 
intermediate vascular plexus in the inner plexiform layer (INL) (Fruttiger, 2007). 
Interestingly, dividing endothelial cells do not respond to hypoxia during the process; 
in fact, endothelial cell-specific Hif factors are reported to be dispensable for 
developmental angiogenesis (Duan et al., 2014). Through this highly organized 
process, retinal vascular networks are structurally optimized to support one of the 
metabolically most demanding tissues in the body (Yu and Cringle, 2001). 
Various mechanisms for the temporal and functional involvement of neuronal cells in 
vascular development have been proposed. Retinal ganglion cells support the 
astrocytes in guiding the formation of the superficial vascular plexus (Liu et al., 
2013), whereas amacrine and horizontal cells guide deep and intermediate plexus 
formation and vasculature maturation (Usui et al., 2015) in a VEGF/Hif1a-dependent 
manner. Neuroprogenitor cells play a role of particular interest, since neurogenesis 
proceeds in parallel with angiogenesis (Hawkins and Davis, 2005). These 
multipotent undifferentiated cells respond to the hypoxic conditions of early neural 
development by self-renewing and populating the tissue (De Filippis and Delia, 
2011). In anticipation of the increasing neuronal activity, neuroprogenitor cells 
promote vascularization and tissue oxygenation, which itself induces and supports 
neuronal differentiation (De Filippis and Delia, 2011).  
The molecular mechanisms of this interaction between the proliferating 
neuroprogenitors and the developing vasculature are only partially understood. It has 
been previously established (Caprara et al., 2011) that Hif1a-mediated responses to 
hypoxia by retinal neuroprogenitor cells are involved in maintaining appropriate 
VEGF gradients during vascular development (Okabe et al., 2014) and in influencing 
the formation of the astrocytic network and the deposition of the vascular 
extracellular matrix (Nakamura-Ishizu et al., 2012). However, the involvement of 
neuroprogenitor-specific Hif2a has yet to be described, although the importance of 
Hif2a in vascular development is indicated by the severe retinal vasculature 
abnormalities observed in Hif2a-/- mice (Ding et al., 2005). Hif2a is structurally similar 
to Hif1a, but shows distinct localization and often non-redundant responses to 
hypoxia (Hu et al., 2003; Mowat et al., 2010), especially during development 
(Scortegagna et al., 2003). Hif2a is the major regulator of erythropoietin (EPO), 





















and disease (Haase, 2013). Additionally, like Hif1a, Hif2a drives VEGF expression 
(Majmundar et al., 2010).  
In the present study, we observed that Hif2a ablation in murine neuroprogenitor cells 
delayed retinal vascular development, resulting in profound abnormalities persisting 
into adulthood, including fewer arteries and veins, and reduced density of the deep 
vascular plexus peripherally. We found reduced expression of Vegf and Epo and 
increased levels of endostatin, known for its powerful anti-angiogenic properties in 
disease (Walia A et al., 2015) but not previously implicated in vascular development. 
Overall, our findings contribute to an understanding of the interaction between 
neuronal and endothelial cells, demonstrating how neuroprogenitors promote normal 
vascular development through the oxygen-dependent transcription factor Hif2a. 
These observations may have implications for pathological conditions in which the 
neurovascular cross-talk is impaired. 
 
Results: 
Hif2a is expressed in RPE, ganglion cells, astrocytes and neuroprogenitors of 
the post-natal developing retina 
We investigated expression of Hif2a by immunofluorescence in retinal sections at 
successive postnatal time points (Fig. 1A). Nuclear expression of the protein was 
detected in the GCL (all ages), the retinal pigment epithelium (RPE; Fig. 1A and Fig. 
1D; yellow-arrowheads), the neuroblastic layer (NBL; P0 to P6) and the INL (P9). 
The anatomical location of Hif2a+ cells in the neuroretina suggested their ganglion 
cell and neuroprogenitor nature (white-arrowheads Fig. 1A), which was confirmed by 
co-staining with cellular markers on P3 sections: Pax6+ cells in the GCL (Fig. 1B; 
green arrow-heads) were ganglion cells (Hitchcock et al., 1996); Pax6+ cells in the 
NBL were neuroprogenitors (Marquardt et al., 2001) (Fig. 1B; white arrow-heads). 























Cre expression and Cre-mediated recombination affects the post-natal 
neuroretina in the CreTrp1 line 
Since Hif2a appeared to be strongly expressed in neuroprogenitors during post-natal 
eye development, we sought to determine its role by Cre/lox deletion of Hif2a in 
these cells.  
The Cretrp1 transgenic line expresses Cre recombinase under the tyrosinase-related 
protein 1 (Tyrp1) promoter and has been historically employed to knock-out genes 
conditionally in pigmented ocular tissues such as the RPE and the iris (Mori et al., 
2002). Since concerns on cell specificity were previously raised (Thanos et al., 2012) 
we investigated Cre-mediated recombination by crossing Cretrp1 with the reporter line 
ROSAmT/mG (Muzumdar et al., 2007). Unexpectedly, at P1 membrane GFP (mGFP) 
reporter expression was evident not only in the RPE but also throughout the optic 
nerve and neuroretina (Fig. 2A,B). Although Cre activity appeared strongest in the 
peripheral retina (Fig 2A,B), significant activity was also evident in columns of cells in 
the central retina (Fig 2C) suggesting clonal expansion of cells resulting from Cre-
mediated recombination in a common neuroprogenitor (Reese et al., 1999). Cre 
recombinase signal was evident on immunohistochemistry in Pax6+ 
neuroprogenitors of the NBL (Fig. 2D), and active transcription was detected in 
whole neuroretina (Fig. 2E). Evidence of Cre protein in the ONL as late as P14 (Fig. 
2F and Fig. S1A) indicated that Tyrp1 promoter activity is more sustained than 
previously described (Mori et al., 2002). 
After crossing the CreTrp1 line with Hif1af/f, Hif2af/f and Hif1af/f;Hif2af/f lines (Gruber et 
al., 2006; Ryan et al., 2000), we investigated the impact of ectopic Cre recombinase 
expression by assessing the expression of Hif family members in P6 retinae by RT-
qPCR (Fig. 2G): Hif1a expression was significantly reduced in CreTrp1;Hif1af/f and 
CreTrp1;Hif1af/f;Hif2af/f mice, while Hif2a was reduced in CreTrp1;Hif2af/f and 
CreTrp1;Hif1af/f;Hif2af/f mice.  
Overall, the results indicated Cre-mediated recombination in retinal 
neuroprogenitors, not limited to ocular pigmented tissues as originally described 























As we previously reported a major role for Hif1a regulation on whole eye 
development by employing the same transgenic line (Lange et al., 2012), we 
compared eye size and morphology over time and observed no effect (Fig. S1B,C). 
Adult eyes were macroscopically normal (Fig. S1B) and showed no sign of 
photoreceptor (PR) degeneration (Fig. S1D,E).  
CreTrp1;Hif2af/f and CreTrp1;Hif1af/f;Hif2af/f mice show severely delayed 
developmental angiogenesis 
We examined retinal vascular development at P6 (Fig. 3A and Fig. S2A) and 
identified a marked delay in the primary plexus formation both in CreTrp1;Hif2af/f and 
CreTrp1;Hif1af/f;Hif2af/f in terms of both radial expansion (Fig. 3B) and vascularised 
area (Fig. 3C) compared with controls and CreTrp1. In both lines, fewer branch points 
were present in the advancing angiogenic front (Fig. 3D and Fig. S2A) and mature 
capillary bed (Fig. 3E and Fig. S2A). Occasionally, the forming vasculature in the 
Hif2a KO retina showed abnormally curved arteries (Fig. S1F), reported to be a sign 
of vascular pathology (Han, 2012). Hif2a KO lines showed no significant reduction in 
tip cell differentiation and/or filopodia along the angiogenic front (Fig. 3F-I), nor an 
increase in vascular regression, identified by empty extracellular matrix sleeves 
(Phng et al., 2009) (Fig. S2B,C). Since sprouting angiogenesis is typically dependent 
on the Notch-signalling pathway in endothelial cells (Hellström et al., 2007), we 
studied the expression of the major Notch receptors (Notch1 and Notch4), ligands 
(Dll1 and Dll4) and downstream effectors (Hes1 and Hey1) on the transcriptome of 
P2 FACS-sorted endothelial cells (Fig. 3J) and, in accordance with the absence of 
changes at the angiogenic front, we detected no significant differences in cells sorted 
from Hif2a KO mice.  
Radial progression of the primary plexus was delayed in Hif2a KO lines when 
compared to CreTrp1 and CreTrp1;Hif1af/f, as measured centrally in terms of vascular 
density at P3 and P6 (Fig. 4A). Delayed angiogenesis also affected the formation of 
the deep and intermediate plexi (Fig. 4A, B). Hypoxic tissue between the superficial 























Despite delayed retinal vascular development, the hyaloid vasculature regressed 
almost normally in Hif2a KO mice: at P13, only few foetal vessels persisted, while at 
P18 few remnants were evident on CreTrp1;Hif2af/f and CreTrp1;Hif1af/f;Hif2af/f mice 
(Fig. S1G).  
The pigmented tissue of the iris expresses Cre in the CreTrp1 mouse (Lange et al., 
2012; Mori et al., 2002); however, iridal vasculature developed normally in all the 
lines studied, with no signs of persistent pupillary membrane in adulthood (Fig. S1H). 
Vascular abnormalities were still present in young adult Hif2a KO mice at the 
peripheral deep plexus level (Fig. S3B), while the remaining vasculature eventually 
developed a normal configuration (Fig. 4A). Hif1a KO lines showed a marked delay 
in the formation of the intermediate plexus (both centrally and peripherally) (Fig. 4A), 
consistent with previous observations (Caprara et al., 2011). No changes in terms of 
vascular permeability were observed (Fig. S1I), indicating development of an intact 
blood-retinal barrier.  
Strikingly, Hif2a KO lines developed fewer arteries and veins (Fig. 4D,E) as 
confirmed by fluorescein angiography (Fig. S3C), together with an increased number 
of branch points (Fig. S3D), suggestive of a compensatory mechanism to enable 
fewer major vessels serve a greater portion of the tissue. 
CreTrp1; Hif2af/f and CreTrp1;Hif1af/f;Hif2af/f retinae show decreased endothelial 
proliferation, normal Vegf/Vegfr2 signalling and increased endostatin levels 
At P6, the proportion of actively dividing endothelial cells at the angiogenic front 
(visualised by EdU incorporation) was significantly reduced in CreTrp1;Hif2af/f and 
CreTrp1;Hif1af/f;Hif2af/f mice (Fig. 5A,B), as was the total number of endothelial cells 
(Fig. S4A). 
Endothelial cell migration and proliferation during development are mainly driven by 
VEGF-A through VEGFR2 interaction on tip and stalk cells (Gerhardt et al., 2003) 
and decoy regulation of VEGF-A content by neural progenitors (Okabe et al., 2014). 
Retinae of P5 CreTrp1;Hif2af/f presented slightly reduced levels of Vegfr2 (Fig. 5C,D), 
possibly a consequence of the reduced endothelial cells number (Fig. S4A), but the 
ratio of active (phosphorylated) receptor over total Vegfr2 was unaffected (Fig. 5C-





















analysis suggested that the intracellular VEGF signalling was not significantly 
impaired in this genotype and that factors other than VEGF-A may have been 
involved in driving the phenotype.  
To investigate signalling molecules accounting for the delayed angiogenesis in Hif2a 
KO lines, we performed angiogenesis-specific proteome profiling of whole P6 retinal 
protein extracts. The most prominent change was detected for endostatin/collagen 
XVIII (Fig. 5F,G; red). Quantitative analysis of the 20 kDa Collagen XVIII-derived 
anti-angiogenic fragment endostatin (Walia A et al., 2015) by western blotting 
demonstrated significantly higher levels in CreTrp1;Hif2af/f mice (Fig. 5H,I).  
Cre-mediated recombination occurs in neuroprogenitors in the CreTrp1 line 
To determine the extent of Cre-mediated recombination in the CreTrp1 line, we 
performed flow cytometry on CreTrp1;ROSAmT/mG dissociated retinae (Fig. 6A). We 
found that almost 50% of live retinal cells from neuroretinae of both young and adult 
mice were affected (Fig. 6B) (46.08±1.18% at P5; 48.57±1.40% in adults). qPCR 
analysis on mRNA from FACS-sorted mGFP+ cells from CreTrp1;ROSAmT/mG and 
CreTrp1;Hif2af/f;ROSAmT/mG showed substantial reductions in Hif2a and its main 
transcriptionally-regulated targets, Vegf and Epo (Fig. 6C). Interestingly, few GFP+ 
cells could be detected in CreTrp1;ROSAmT/mG dissociated brain tissue, whereas no 
GFP+ cells could be detected in spleen (Fig. S5C). 
In the mouse retina, neurogenesis is characterised by two waves of cellular 
differentiation: the first (E11-E18) is characterised by the differentiation of early 
neuroprogenitors into ganglion cells, horizontal cells, cone photoreceptors, 
approximately half of the rod photoreceptors and a subset of amacrine cells. During 
the second wave (P0 to P8), remaining late neuroprogenitor cells divide 
asymmetrically to generate the remaining of rod photoreceptors and amacrine cells, 
all bipolar cells and Müller glia (Cepko, 2014). We immuno-phenotyped GFP+ cells 
from adult CreTrp1;ROSAmT/mG retinae by flow cytometry (refer to Table S1, S2 and S3 
and Fig. S5 for strategy and markers used). All major neuroretinal cell types showed 
highly similar proportions of GFP positivity at approximately 50% of the total live sub-
population (Fig. 6D). Each major retinal cell type was represented within the mGFP+ 
sub-population similarly to whole dissociated retinae, with the exception that Müller 





















mediated recombination occurred in around 50% of an early embryonic retinal 
neuroprogenitor, from which late retinal neuroprogenitors and every major cell type 
of the neuroretina originated.  
Murine retinal angiogenesis starts at P0 and late neuroprogenitor cells are known to 
be involved in this process (Caprara et al., 2011; Nakamura-Ishizu et al., 2012; 
Okabe et al., 2014). We sought to confirm whether late neuroprogenitors were 
affected by Cre-mediated recombination. We first assessed Pax6, a marker of 
neuroprogenitors (Marquardt et al., 2001) as well as ganglion cells and a fraction of 
amacrine cells (Hitchcock et al., 1996), and its co-localization with mGFP in P1 retina 
of CreTrp1;ROSAmT/mG mice (Fig. 7A,A’). Numerous mGFP+ cells appeared to 
ensheathe Pax6+ nuclei, particularly those present in the NBL, most of which at this 
stage of retinal development are dividing/differentiating late neuroprogenitors 
(Marquardt et al., 2001; Nakamura-Ishizu et al., 2012). Quantification by flow 
cytometry showed that 50% of Pax6+ cells stained positive for GFP in P5 
CreTrp1;ROSAmT/mG retinae (Fig. 7B,C). 
To validate these findings, we crossed CreTrp1 with GFPRlbp1 mouse, in which post-
natal GFP expression labels late neuroprogenitors (Vázquez-Chona et al., 2009). 
FACS-sorted GFP+ cells from P5 CreTrp1;GFPRlbp1 showed active Cre recombinase 
expression (Fig. 7E), whereas P5 GFP+ retinal neuroprogenitors isolated from 
CreTrp1;Hif2af/f;GFPRlbp1 presented significantly reduced Hif2a, Vegf and Epo 
expression (Fig. 7F). These findings demonstrate the extent of Cre expression and 
Cre-mediated excision of floxed genes in late neuroprogenitors of CreTrp1 lines. 
To understand in more detail how late neuroprogenitors are structurally related to the 
forming vasculature, we performed iB4 staining on whole-mounted retinae of P4 
wild-type GFPRlbp1 mice, followed by three-dimensional rendering. Long cellular 
processes originated from GFP+ late neuroprogenitors were visible between the NBL 
and the GCL, intercalating with the forming vasculature (Fig. 7G). Neuroprogenitor 
processes engaged in a close association with endothelial cells at the angiogenic 
front (red arrow-heads, Fig. 7H) as well as with post-mitotic endothelial cells in the 























Retinal ganglion cells also stain positive for Pax6 (Hitchcock et al., 1996) and are 
key regulators of astrocytes and endothelial cells during developmental 
angiogenesis, through mechanisms that appear to be Hif-independent (Sapieha et 
al., 2008). We observed co-localisation of the ganglion cell marker neurofilament 
with GFP in CreTrp1;ROSAmT/mG mice at P5 (Fig. S6A-B’). Since the arrangement of 
axonal extensions was similar, both centrally and peripherally (Fig. S6C), a 
pronounced effect on ganglion cells viability by Cre-mediated recombination and/or 
downregulation of Hif factors appears unlikely.  
Other perivascular cells are affected by Cre-mediated excision but do not 
show strong phenotypic alterations 
Retinal astrocytes play a key role in retina postnatal vascular development (Fruttiger, 
2007). Unexpectedly, we found clear mGFP co-localisation with the immature 
astrocyte marker Pdgr-a (Fig. 8A,A’) and the mature astrocyte marker Gfap (Fig. 8B) 
on P5 CreTrp1;ROSAmT/mG eyes. By flow cytometry, we confirmed GFP and Pdgfr-a 
co-localisation in around 40% of astrocytes (Fig. 8C), detected active Cre expression 
in GFP+ astrocytes from P5 CreTrp1;ROSAmT/mG mouse  (Fig. 8E) and found a marked 
reduction in Hif2a, Vegf and Epo expression in GFP+ astrocytes derived from Hif2a 
KO mouse (Fig. 8F). 
Although previous reports (Scott et al., 2010; Weidemann et al., 2010) found no role 
for astrocyte-derived Hifs or Vegf in developmental retina angiogenesis, a more 
recent study (Duan et al., 2014) identified the importance of astrocyte-specific Hif2a 
in regulating astrocyte proliferation and network formation, with consequent 
alterations on vascular formation. We identified in CreTrp1;Hif2af/f mice no clear 
morphological differences in the astrocytic network at P3 (Fig. 8G,H), consistent with 
a possible difference in the penetrance or efficiency of Cre recombinase in astrocytic 
lineages.  
Hif1a in retinal neuroprogenitors can influence the deposition of extracellular 
fibronectin by retinal astrocytes (Nakamura-Ishizu et al., 2012); we identified similar 
defects in fibronectin deposition in Hif1a KO lines but no substantial difference in 























Pericytes participate in developmental angiogenesis and contribute to vessel stability 
and maturation (Bergers and Song, 2005). We detected around 20% of Ng2+ 
pericytes to be GFP+ in P5 CreTrp1;ROSAmT/mG (Fig. S8A,B), but this did not impact 
on pericytes positioning around forming vasculature (Fig. S8C,D).  
Resident myeloid cells (microglia) are required to promote branching patterning and 
tip cell filopodia formation (Fantin et al., 2010). The CreTrp1;ROSAmT/mG mouse 
showed approximately 30% of CD45+/CD11b+ cells positive for GFP (Fig. S8E,F) but 
we identified no difference (Fig. S8G) at the angiogenic front of Hif2a KO lines.  
Viral vector delivery of Cre recombinase to a subset of Hif2af/f late retinal 
neuroprogenitors recapitulates the delayed vascular development of Hif2a KO 
mice 
To investigate the role of late neuroprogenitor-specific Hif2a in directing normal 
retinal vascular development, we used a recombinant adeno-associated virus (AAV) 
serotype 7m8 (Dalkara et al., 2013) to deliver the reporter gene RFP 
or Cre recombinase under the control of the neuroprogenitor-specific promoter 
Nestin (Tronche et al., 1999). 
To target late neuroprogenitors efficiently, we injected AAV-7m8 intravitreally (Fig. 
S9A) soon after birth (P0.5-P1) and collected tissue at P6 (Fig. S9B). Other 
collection time points (P4, P18) were chosen to assess viral transduction and 
tropism. First, we observed Nestin-driven expression of RFP 3 days post-injection 
(P4) in cells at various levels of the NBL (Fig. 9A) with elongated morphology 
consistent with that of neuroprogenitors (Surzenko et al., 2013). To confirm viral 
tropism, GFPRlbp1 mice were injected with AAV-Nestin.RFP and P4 dissociated 
retinae were analysed by flow cytometry. Such approach is sufficiently sensitive to 
assess close-to-total co-localisation of transgene (RFP) expression in GFP-
expressing cells (Fig. 9B, C), supporting the high progenitors-specific tropism of this 
vector configuration. Nonetheless, this investigative design likely underestimates 
AAV-Nestin tropism and efficiency of transduction due to unavoidable experimental 
limitations: the relatively short time interval between AAV injection and analysis does 
not allow identification of all cells transduced, some of which express yet 





















neuroprogenitors causes dilution of the episomal AAV vector genome in daughter 
cells, and the Nestin promoter is inactive in neuroprogenitors differentiating into 
neurons or Müller glia. 
The efficacy of the AAV-Nestin.Cre vector was validated by intravitreal administration 
to ROSAmT/mG eyes, where it produced columns of GFP+ cells in the ONL (Fig. S9C), 
reminiscent of those seen in the CreTrp1 mouse (Fig. 5C). Sorted GFP+ cells from 
virally injected Hif2af/f;GFPRlbp1 mice showed limited reduction in Hif2a expression 
(Fig. S9C), in accordance with the limited number of GFP+ cells infected.  
To determine which stage(s) of late neuroprogenitors is transduced by AAV-Nestin- 
vectors, we collected AAV-Nestin.Cre-injected ROSAmT/mG eyes after completion of 
retinal development (P18) and characterised the wide-spread (Fig. 9E) GFP+ 
population by flow cytometry and immunohistochemistry, which identified CD73+ 
photoreceptors (43%), Müller glia (38%) and Pkc-α+ rod-bipolar cells (5%; Fig. 9D 
and  Fig. S9F-G). The absence of reliable GFP/cone arrestin co-localisation (Fig. 
S9H), typical morphology of rod photoreceptor cell bodies and outer segments (Fig. 
S9I; yellow- and white arrow-heads, respectively) and absent co-localisation of the 
latter with PNA-stained cone outer segments (Fig. S9J,K) confirmed rod identity of 
GFP+ photoreceptors. We concluded that AAV-Nestin recombinant vectors injected 
at P0.5-P1 almost exclusively target the latest sub-class of retinal neuroprogenitors, 
which generates both Müller glia and a proportion of rods (Cepko, 2014). With this in 
mind, we investigated the effect of virally-mediated Hif2a ablation in these cells on 
retinal angiogenesis (Fig. 9E). Retinae from Hif2af/f;ROSAmT/mG mice injected with 
AAV-Nestin.Cre showed a significant reduction in radial expansion, vascularised 
area and branch points both at the angiogenic front and in the capillary bed (Fig. 
9F,G). In addition, the number of major arteries and veins was also reduced (Fig. 
9H-I). Similarly to CreTrp1;Hif2af/f mice (Fig. 4H,I), also AAV-Nestin.Cre-injected 
Hif2af/f retinae showed increased levels of the anti-angiogenic peptide endostatin 
compared to AAV-Null-treated  eyes (Fig. 9J,K).  
Overall, these results closely replicate the phenotype observed in CreTrp1;Hif2af/f and 
strongly support the hypothesis that late neuroprogenitor-specific Hif2a is a critical 























Since the CreTrp1 line was originally designed to target the RPE specifically and this 
tissue presented strong postnatal Hif2a expression, we investigated the role of RPE-
specific Hif2a on retinal angiogenesis by means of a similar viral vector approach. To 
target the RPE, we chose to use a recombinant HIV1-based lentiviral vector and a 
ubiquitous promoter (spleen focus-forming virus promoter; SFFV) (Balaggan and Ali, 
2012). A single vector administration was performed subretinally into ROSAmT/mG and 
Hif2af/f;ROSAmT/mG mice (Fig. S10A,B). Between 20% and 40% of the RPE 
monolayer was transduced (Fig. S10C) and no other cell types appeared GFP+ by 
P12 (Fig. S10D). At P6, we detected no differences in terms of radial expansion and 
vascularised area (Fig. S10E-G), nor of numbers of arteries and veins (Fig. S10H,I). 
Therefore, we concluded that RPE-specific Hif2a is unlikely to influence retinal 
vascular development. 
Viral vector delivery of Hif2a to Hif2a KO late neuroprogenitor cells partially 
rescues the vascular phenotype 
To rescue the vascular phenotype of Hif2a KO mice, we cloned Hif2a coding 
sequence into the AAV-Nestin vector and delivered it intravitreally to CreTrp1;Hif2af/f 
mice following the same experimental paradigm (Fig. S9A,B). Hif2a expression was 
significantly increased in GFP+ cells sorted from P6 Hif2a-injected 
CreTrp1;Hif2af/f;GFPRlbp1 eyes compared to Null-treated eyes (Fig. 10F). No change in 
radial expansion and vascularised area (Fig. 10A,B) was detected in CreTrp1;Hif2af/f 
mice treated with AAV-Nestin.Hif2a, which may depend on limitations in this 
experimental set-up compared to the previously described AAV-Nestin.Cre 
experiment, including: insufficient levels of Hif2a expression per cell, transient 
transgene expression due to cell differentiation or cell division, short treatment 
window. Nonetheless, CreTrp1;Hif2af/f mice treated with AAV-Nestin.Hif2a presented 
more branch points at the angiogenic front (Fig. 10C), as well as more arteries (Fig. 
10D,E), and these changes were accompanied by an increase in the percentage of 
dividing endothelial cell nuclei (Fig. 10G,H) as well as an increase in the number of 
total endothelial nuclei at the angiogenic front (Fig. 10G,I). In CreTrp1;Hif2af/f mice, 
retinal endostatin was also significantly attenuated by AAV-Nestin.Hif2a 





















findings strongly support the hypothesis that neuroprogenitor-specific Hif2a promotes 
endothelial cell division and vascular bed formation during normal development.  
 
Discussion: 
Owing to its accessible laminar anatomy and its uniquely high metabolic demand, 
the murine retina has been used extensively to study the consequences of neuronal 
hypoxia (Caprara et al., 2011; Usui et al., 2015). Historically, astrocytes have been 
considered the primary oxygen sentinels of the retina, however their importance is 
questioned by evidence of the dispensable role of the Hif pathway in these cells 
(Scott et al., 2010; Weidemann et al., 2010). Recent studies have elucidated the role 
played by neuronal cells as oxygen and nutrient sensors, highlighting their ability to 
drive and regulate physiological and pathological angiogenesis (Nakamura-Ishizu et 
al., 2012; Usui et al., 2015). In the current study we present evidence for a novel 
mechanism, centered on Hif2a and neuroprogenitors of the retina, which dynamically 
interact with the forming vasculature at the angiogenic front, promoting vascular 
development in an astrocyte-independent manner. Interestingly, the iridal 
vasculature, which is also dependent on appropriate oxygen management (Lange et 
al., 2012), developed normally (Fig. S1), making our findings strictly specific to retinal 
angiogenesis. 
Initial evidence was obtained from experiments performed on the CreTrp1 line, 
designed  as a tool to generate efficient RPE-specific knock-outs (Mori et al., 2002). 
However, the promoter driving Cre (tyrosinase-related protein 1, an enzyme involved 
in pigment formation) is not RPE-specific: we have shown (Fig. 2) diffuse post-natal 
Cre expression and Cre-mediated recombination in the neuroretina, in a peripheral-
to-central pattern. This is reminiscent of the CrePax6 line, extensively used to target 
neuroprogenitors and neurons in similar studies (Nakamura-Ishizu et al., 2012; 
Okabe et al., 2014). One possible explanation for the ectopic Cre recombinase 
expression in retinal neuroprogenitors is the involvement of the ciliary body (CB): this 
region hosts a pool of multipotent stem cells specialized in becoming precursors 
cells for retinal neurogenesis and anterior eye development (Frøen et al., 2013). 
Since this region of the eye shares a common developmental origin with pigmented 





















Cre expression may be induced in an upstream common multipotent neuroprogenitor 
in the CreTrp1 mouse. Since we detected occasional cells affected by Cre-mediated 
excision in the brain (Fig. S5C), which also contains distinctive pigmented cells (i.e. 
the neurons in the substantia nigra pars compacta), this may confirm Cre expression 
as a result of the early activation of the pigment synthesis pathway. However, this 
does not explain why non-neuronal cells such as astrocytes, pericytes and microglia 
are also affected by Cre-mediated excision in this line (Fig. 8 and Fig. S8). The 
distinctive phagocytic abilities of these cells, their close proximity and functional 
interaction with developing neurons and their putative ability to undergo cell 
fusion/material transfer (Ogle et al., 2005) offers a plausible explanation. 
Off-targeting effects in the Cre/lox system are well recognized, making data 
interpretation often difficult (Harno et al., 2013). We included the Cre-expressing 
group as a control, and confirmed our modified, neuroprogenitors-centered 
hypothesis through a more reliable cell-specific viral vector-based approach. The 
severity of the angiogenic delay observed in Hif2a KO lines, compared with related 
ones (Nakamura-Ishizu et al., 2012), was particularly pronounced (Fig. 3-4), with 
persistent differences in the deep vascular plexus evident to adulthood. In the wild-
type neuroretina, Hif2a stabilization was detected until (at least) P9 in areas rich in 
neuroprogenitors/differentiating neurons/glia (Fig. 1), even though the on-going 
vascularization should have already improved the deep retinal hypoxia typical of the 
first week of life. This observation is consistent with the hypothesis that Hif2a is more 
susceptible to chronic (Lin et al., 2011) and subtle levels of hypoxia (Appelhoffl et al., 
2004) compared with Hif1a and, therefore, more dynamically modulated.  
Our comparison between the two main hypoxia responsive α-subunits supports a 
more prominent role of Hif2a in the developing neuroretina, consistent with the 
findings of previous studies (Rattner et al., 2014). Although aware of the well-
described developmental role played by neuroprogenitor-specific Hif1a (Caprara et 
al., 2011), the dramatic consequences of Hif2a ablation were unexpected, not only in 
terms of temporal delay of angiogenesis and reduction in vascular complexity (Fig. 3-
4), but also in terms of irreversible abnormalities such as the reduction in the number 
of major retinal vessels and vascular density of the intermediate plexus (Fig. 4 and  





















vascular regression/pruning, tip cells behavior, chemotaxis and Vegf signaling; 
remarkably, such parameters remained unchanged (Fig. 3 and Fig. S2B,C), as were 
Vegfr2 activation (Fig. 5C-E) and the expression of Notch/Dll components in 
endothelial cells (Fig. 3J). Instead, late retinal neuroprogenitors of the CreTrp1;Hif2af/f 
mouse showed transcriptional reduction in Vegf and Epo, well known to be angio-
modulatory factors. Since VEGF isoforms are the major drivers of sprouting 
angiogenesis (Gerhardt et al., 2003), vascular outgrowth, capillary bed complexity 
(Ruhrberg et al., 2002) and artery/vein patterning (Dela Paz and D’Amore, 2009), 
this indicates a likely mechanism of Hif2a/progenitor-dependent regulation of 
developmental angiogenesis. Moreover, our own findings are in close accordance 
with the impact of CreNestin -mediated Vegf ablation in brain neuroprogenitors (Fantin 
et al., 2010), resulting in reduced vascular branching despite similar tip cell numbers. 
Persistent hypoxia in the neuroretina (Fig. 4) may also contribute to the defects 
observed in artery/vein patterning, as described in an earlier report (Claxton and 
Fruttiger, 2005). Epo is well recognized for both its neuroprotective and pro-
angiogenic properties (Haase, 2013): although its mechanism of action has yet to be 
elucidated, the results of this study provide further evidence of its participation in 
developmental angiogenesis as previously proposed (Caprara et al., 2011).  
Our experimental evidence (Figs. 5, 9, 10) suggested endostatin as another key 
player. This small protein fragment is derived from the proteolytic cleavage of the 
extracellular matrix component Collagen XVIII operated by an array of proteases 
including metalloproteases (MMPs) and cathepsins (Walia A et al., 2015), some of 
which (MMP-3 and MMP-9) are released during neurogenesis by neuroprogenitors 
to promote matrix remodeling and neural migration (Barkho et al., 2009). Endostatin 
is known for its paracrine anti-angiogenic properties, mainly exerted by blocking 
endothelial cells migration and proliferation via cell-cycle arrest and blockade of 
VEGF/VEGFR2 interaction and signaling (Walia A et al., 2015). Although well 
described for its role in vascular disease, evidence for its involvement in 
developmental angiogenesis is limited to one in vitro study (Schmidt et al., 2004). 
We speculate that hypoxic neuroprogenitors in the avascular peripheral retina and 
avascular deeper cellular layers, while engaging in dynamic interactions with the 
forming vasculature through their cellular processes, suppress endostatin release in 





















they contribute to the formation of a pro-angiogenic molecular gradient ahead of the 
vascular front, as previously described (Gerhardt et al., 2003; Okabe et al., 2014). 
Once neuroprogenitors are reached by the forming vasculature and start sensing 
physiological oxygen level, suppression is relieved and basal levels of endostatin 
help stabilise and maintain mature vasculature. This hypothesis is consistent with the 
endogenous anti-angiogenic nature of endostatin and with the observation that 
mutations in Collagen XVIII gene that downregulate endostatin generation and/or 
activity predispose to the development certain tumours with a prominent vascular 
component (Iughetti et al., 2001).  
Overall, our study describes new levels of structural and molecular association 
between neuronal and endothelial cells, indicating the importance of retinal 
neuroprogenitor/Hif2a-centered mechanisms in the cross-talk between neurogenesis 
and angiogenesis. More broadly, these findings contribute to further the 
understanding of neuro-vascular interactions during normal development, while 
modelling the pathological consequences of mis-communication at the 
neurovascular unit. 
Materials and Methods: 
Animals 
All in vivo procedures were conducted following ethical approval of University 
College London and under the regulation of the UK Home Office Animals (Scientific 
Procedures) Act 1986. This study complied with the ARVO Statement for the Use of 
Animals in Ophthalmology and Vision Research. All genetic combinations were 
maintained on a C57BL/6J background and kept on a standard 12/12 hour light/dark 
cycle with food ad libitum. Genotyping was performed as previously described 
(Lange et al., 2012). The following lines were used (all under C57Bl/6 background): 
transgenic mice expressing Cre recombinase under the control of the RPE cell-
specific tyrosinase-related protein 1 promoter Tyrp1, referred to as CreTrp1 (Lange et 
al., 2012; Mori et al., 2002), Hif1af/f (Ryan et al., 2000), Hif2af/f  (Gruber et al., 2006) 
and combinations as reported in the Results section. Some of these combinations 
were crossed with ROSA26mT/mG (Muzumdar et al., 2007) or with GFPRlbp1 (Vázquez-
Chona et al., 2009). The group “controls” includes all the Cre-negative genotypes 





















differences in basal Hif factors expression and comparable vasculature 
development.  
To consistently collect pups at precise postnatal developmental stages, the morning 
of discovery of a new litter was designated postnatal day (P) 0. Adult mice were 4-6 
weeks old. 
Fluorescein and indocyanine green angiography 
To analyze retinal and corneal vascular phenotype, we performed fluorescein (FA) 
and indocyanin green angiography (ICGA), respectively. Mice were anaesthetized by 
intraperitoneal injections of Dormitor (1 mg/ml; Pfizer Pharmaceuticals, UK) and 
ketamine (100 mg/ml; Fort Dodge Animal Health, UK) mixed with sterile water in 
5:3:42 ratio. Mice were further injected intraperitoneally with 0.2 ml fluorescein (20 
mg/ml) or ICG (5 mg/ml) in PBS 1X. Pupils were dilated using 1% (v/v) tropicamide 
and images were captured on a HRA2 scanning laser ophthalmoscope (Heidelberg 
Engineering, Germany) as previously described (Luhmann et al., 2009). 
Intravitreal injections 
Pups aged between P0.5-P1 were anaesthetized by brief ice exposure (Kim et al., 
2014). Treatments were randomly assigned to left or right eyes before each litter was 
injected. For vasculature development experiments, one eye was injected with either 
AAV-7m8.Nestin.Cre or AAV-7m8.Nestin.Hif2a, whereas the contro-lateral with AAV-
7m8.Null. Eye lids were incised with a 30G needle and eyes were prolapsed. 
Injections were performed with the aid of an operating microscope. The tip (1 mm) of 
a 10 mm 34-gauge needle, mounted on a 5 ml Hamilton syringe (Hamilton Bonaduz 
AG, Switzerland) was inserted slowly through the sclera, below the corneal limbus, 
until the tip of the needle was visible (bevel down) underneath the lens. 0.4 µl of 
vector suspension was injected carefully, monitoring eye swelling. After 10 seconds, 
needle was slowly withdrawn and possible reflux noted down. Pups were quickly 
moved to a heated mat to help post-injection recovery and then transferred back to 























Evans Blue permeability assay 
Evans Blue (Sigma-Aldrich, UK) was prepared (30 mg/ml) in normal saline solution 
(0.9% (w/v) NaCl; Sigma-Aldrich, UK) and sonicated for 5 mins. Solution was then 
filtered through a 5 µm filter (Millipore, UK). Mice were injected intraperitoneally at 4 
ml/kg of body weight (Manaenko et al., 2011) and the dye was left circulating for 16 
hours before overdosing the animal with 0.2 ml pentobarbital (intraperitoneally), 
collecting a sample of blood by cardiac puncture and transcardially perfusing with 
ice-cold PBS 1X to remove unbound dye. Eyes were enucleated, retinae dissected 
and wet weight calculated. Blood-retinal barrier properties were assessed by 
extracting and measuring bound-dye from serum and retinae as reported (Xu et al., 
2001).  
Preparation of flatmount samples, cryo-sections and immunofluorescence 
Ocular size was assessed on freshly enucleated eyes at different time points as 
reported (Lange et al., 2012). Eyes were then fixed in 4% (w/v) PFA on ice for 2 
hours and either dissected for RPE/choroid or retina flat-mounts as previously 
described (Fruttiger et al., 1996) or prepared for cryo-sectioning as described 
(Mowat et al., 2010). 
Whole-mounts were immuno-stained as described (Pitulescu et al., 2010), whereas 
eye sections were immuno-stained as reported previously (Mowat et al., 2010). In 
both cases, primary antibody was incubated overnight at 4°C while secondary 
antibody was incubated for at least 2 hours at room temperature (RT); each step was 
followed by extensive washes. Nuclei were stained by incubation (15 mins; RT) with 
Hoechst 33342 (10 μM) in PBS before mounting. Nuclei rows were counted in 4 
randomly selected sections/animal, both centrally and peripherally.  
Vasculature and resident myeloid cells were visualized by overnight incubation at 
4°C with biotin-conjugated Bandeiraea simplicifolia isolectin B4 (iB4; Sigma-Aldrich, 
UK) at 1:200 dilution, followed by Alexa 633-conjugated streptavidin incubation for 2 
hours at RT. Cone outer-segments were visualized by overnight incubation at 4°C 
with biotin-conjugated Peanut Agglutinin (PNA; Vector Labs, UK) at 1:500 dilution, 





















Hypoxiprobe staining was performed as reported (Gardner et al., 2017). For three 
dimensional reconstructions, immunostained flatmounts were cleared before image 
acquisition following a published protocol (Hama et al., 2011) with modifications. 
Details of the antibodies used for immunohistochemistry can be found in Table S3.  
Imaging and quantification 
Retinal sections and flatmounts were imaged on a confocal microscope (Leica TCS 
SPE, Leica Microsystems, UK). Mosaic stack images were generated to visualize the 
entire retinal vasculature at 512 x 512 pixels resolution with a 10x dry objective, 
whereas higher resolution 1 µm-thick Z-stacks were taken at 1024 x 1024 pixels 
resolution with a 40x oil-immersion objective. Stacks were Z-projected on confocal 
microscope’s proprietary software (Leica LAS AF). Image quantification was 
performed on Image J software (NIH, US); the counter was masked to the genotype 
and treatment received. For vascular quantification, 12 measurements of the forming 
vascular front (normalized to the whole retina extension) were performed and 
averaged for each retina sample. For characterisation of angiogenic front and 
capillary bed, 4 regions per retina were quantified and the mean calculated. When 
required, Z-stacks were three dimensionally reconstructed and surface rendered 
using Imaris software (Bitplane, Switzerland).  
EdU administration and visualization 
Proliferating endothelial cells at the angiogenic front were visualized by 5-ethynyl-2´-
deoxyuridine (EdU) incorporation, following recommended guidelines from a 
commercially available kit (Click-iT EdU kit, Life-Technologies, UK).  
Pups were injected intraperitoneally with 10 µl/g (body weight) 20 mM EdU solution 
and returned to the mother. 4 hours later pups were culled by cervical dislocation, 
eyes collected and fixed in 4% (w/v) PFA for 1 hour at RT. After performing standard 
immunofluorescence for other vascular markers, dissociated retinae were incubated 
in EdU reaction cocktail as per protocol for 30 mins at RT, protecting samples from 
light. After extensive washes in 0.3% (v/v) Triton X-100 PBS 1X, samples were flat-























Production of recombinant adeno-associated viral (AAV) and lentiviral 
particles 
Cre recombinase-coding sequence was cloned into an AAV-ready pD10 backbone, 
into which the Nestin promoter (Lothian and Lendahl, 1997) was added or into a 
Lenti-ready pLenti.SFFV promoter backbone (Tschernutter et al., 2005). The red 
fluorescent protein (RFP) and the murine Hif2a coding sequences were obtained 
from a plasmid available in-house and by PCR amplification on murine retinal cDNA, 
respectively and cloned into the pD10.Nestin promoter backbone. Empty pD10 
backbone served to produce non-expressing (Null) viral particles. The 
resulting constructs were used to generate AAV-7m8 recombinant particles (Dalkara 
et al., 2013) and VSV-G lentiviral particles as previously described (Smith et al., 
2003; Tschernutter et al., 2005). AAV viral particles were purified through an AVB 
Sepharose column and concentrated to a final volume of 150-200 μl sterile PBS 1X 
using Vivaspin 4 (10 kDa) concentrators (Sartorius AG, Germany). Lentiviral particles 
were concentrated by ultra-centrifugation (50000 x g; 2.5h, 4°C) to a final volume of 
200 μl sterile PBS 1X. 
Tissue dissociation, immunostaining, flow cytometry sample acquisition and 
cell sorting 
Dissected mouse retinae were dissociated into a single cell suspension for 
subsequent cell staining. Papain neurosphere dissociation kit (Miltenyi Biotec) was 
used, according to the manufacturer’s instructions. Spleen and brain samples were 
homogenized using a 2.5 mL syringe plunger and a 70 µm filter. 
Once dissociated, samples for extracellular staining (see Table S3) were spun down 
at 320xg for 5 min and stained in the dark in DMEM+ medium (supplemented with 
2% FCS and 10mM HEPES) for 30 min on ice. Non-directly conjugated anti-NG2 
antibody was followed by 30 mins incubation with goat anti-rabbit AF633 secondary 
antibody (Thermo Scientific, UK). Cells were then washed and resuspended in fresh 
DMEM+, filtered and stained with either SYTOX Blue (Thermo Fisher Scientific, UK) 
at a final concentration of 0.3 mM or DRAQ7 (Biostatus, UK) at a final concentration 






















Instead, samples for intracellular staining (see Table S3) were spun down at 320xg 
for 5 min and stained in the dark with the LIVE/DEAD Fixable Violet Cell Stain 
(Thermo Fisher Scientific, UK) diluted in DMEM+ media for 30 min on ice.  Cells 
were then washed with DMEM+ media and fixed in 2% PFA for 30 min on ice in the 
dark. Cells were washed once with 1X PBS and then resuspended in True Nuclear 
Transcription Factor permeabilisation buffer (BioLegend, UK) for 30 min on ice, in 
the dark. Cells were then washed and resuspended in neat donkey serum for 10 
min. All the primary antibodies were diluted in True Nuclear permeabilisation buffer 
and added directly to the appropriate samples containing the donkey serum for an 
additional 30 min on ice, in the dark. With the exception of directly conjugated 
antibodies, samples were then washed with 1X PBS and resuspended in neat 
donkey serum for 10 min just prior to the addition of either goat anti-mouse-AF633 or 
goat anti-rabbit-AF633 secondary antibody (Thermo Fisher Scientific, UK) for 30 min 
on ice, in the dark. Samples were then washed and resuspended in 1X PBS. Please 
refer to Tables S1 and S3 for more detailed antibody information. 
The samples were acquired using a 5-laser BD LSR Fortessa X-20 Analyser or 
acquired and sorted on a 5-laser BD Influx cell sorter, both equipped with 355nm 
(UV), 405nm (violet), 488nm (blue), 561nm (yellow) and 640nm (red) lasers. Prior to 
cell acquisition, samples were filtered through a 35µm cell strainer to prevent cellular 
aggregation. 
Real-time PCR 
Whole retinae were homogenized and RNA was extracted using RNeasy Mini Kit 
(Qiagen, UK). RNA from cells sorted into TRIzol plus (Thermo Fisher Scientific, UK) 
was extracted using Direct-zol microprep RNA kit (Zymo Research, USA). cDNA 
preparation was performed using QuantiTect Reverse Transcription Kit (Qiagen, UK) 
following manufacturer’s instructions. Absolute and relative quantification of genes of 
interest was quantified by real-time probe-based PCR against endogenous Actb (and 
Pecam-1 for sorted endothelial cells) expression levels. Real-time PCR mastermix 
was used as per recommended guidelines (Quantabio, USA). Primers were first 
assessed for optimal efficiency of amplification on known amounts of cDNA. Assays 





















second exon, which is flanked by loxP sites in Hif1af/f and Hif2af/f lines. This allowed 
detection of gene knocked-out in Cre/loxP lines. Primers for VEGF were designed to 
detect all VEGF isoforms. For absolute quantification (Hif2a; Cre), in-house plasmids 
bearing the coding sequence of the target genes were used. Primer sequences 
(Thermo Scientific, UK) and probes (Roche Diagnostics, UK) are reported in Table 
S4.  
Western Blotting 
Total and phosphorylated (Y1145) VEGFR2 and endostatin levels were determined 
on whole retinae, snap frozen in liquid nitrogen after dissection. Tissue was lysed by 
repeated pipetting and following incubation for 30 mins on ice with RIPA buffer 
(Thermo Scientific, UK) with phosphatase (Thermo Fisher Scientific, UK) and 
protease inhibitor (Sigma Aldrich, UK). Equal amounts of protein were run on a 
reducing 4-12% gradient sodium SDS-PAGE gels (Thermo Fisher Scientific, UK). 
House-keeping proteins b-actin or b-tubulin were probed as loading controls. 
Separated proteins were electrotransferred to PVDF membranes (Millipore, UK), 
blocked for 1 hr at RT in 5% (w/v) BSA 0.05% (v/v) Tween-20 in PBS 1X and then 
incubated overnight at 4°C with primary antibodies (see Table S3). After extensive 
washes in 0.05% (v/v) Tween-20 PBS 1X, membranes were incubated in secondary 
antibodies for 2 hr at RT. Chemiluminescence detection was performed using a 
Fujifilm LAS-1000 Luminescence Image analyser after incubation with enhanced 
luminescence reagent (ECL plus; GE Healthcare, UK). Band intensities were 
quantified using Image J software and normalized to the house-keeping gene. For 
genotype comparisons, control and KO samples were obtained from the same litter 
to control for intragroup variability, whereas CreTrp1 was obtained from litters of the 
most similar age possible. For treatment comparison, eyes were paired and 
compared to the Null-treated contralateral eye. 
Mouse angiogenesis proteome profiler array 
Retinal protein extracts (processed exactly as for Western Blot analysis) were 
analyzed for angiogenesis-related molecules on a proteome profiler array (R&D 
Systems, UK) and developed according to the manufacturer's guidelines. Images 





















with ImageJ. Membranes were normalized to each other using positive control spots 
and background reading (Chu et al., 2016). 
Statistical analysis 
Data are presented as mean±s.e.m and sample sizes are reported in each figure 
legend. Each experiment on animals was performed at least on 2 independent litters 
of a given genotype. Data were plotted and analyzed for statistical significance using 
Graphpad Prism software (Graphpad Software Inc., USA). First, normal distribution 
was assessed for each group by Kolmogorov-Smirnov test. Parametric statistical 
tests (two-tailed t-test and one- or two-way ANOVA) were used to compare between 
averages of two or more groups, with post-hoc Tukey’s or Bonferroni’s multiple 
comparison test. P values less than 0.05 were considered statistically significant. 
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Fig. 1: Expression of Hif2a in the eye after birth. (A) Hif2a staining was detected 
in cell nuclei in the GCL at all ages analysed, in the NBL at P0, P3 and P6 and in the 
INL at P9 (white arrow-heads), as well as RPE nuclei (orange arrow-heads). (A’) 
Absence of specific Hif2a signal in P6 CreTrp1; Hif2af/f tissue. (B) Co-labelling of Hif2a 





















(various locations of the NBL; see white arrow-heads). (C) Co-staining with Pdgfr-a 
in astrocytes. Panel (D) shows Hif2a in the RPE, visualised on bright-field (BF) 























Fig. 2: Cre expression is not limited to RPE in the CreTrp1 line. (A) Whole eye 
section from a P1 CreTrp1 crossed with ROSAmT/mG line. Membrane-localized GFP 
expression present throughout the whole neuroretina, particularly in the peripheral 
region. (B) Retinal and choroid/RPE flatmounts of CreTrp1;ROSAmT/mG P1 eye 
showing peripheral GFP expression in the retina and RPE. (C) High-magnification of 
central and peripheral regions (age: P1); GFP+ cells are organised in columns, 
reminiscent of developmental clonal expansion. (D) Pax6 and Cre staining of P1 eye 
section (co-staining highlighted by white-arrowheads). (E) RT-qPCR analysis of Cre 
in P5 whole retinae mRNA extracts. n=5. (F) Cre staining of a P14 eye section 
(highlighted by white-arrowheads). Non-specific binding of secondary antibody to 
blood vessels (red-arrowheads; also refer to Fig. S1A). (G) RT-qPCR analysis of 





















percentages of the controls (n=5-8). ANOVA and Tukey’s multiple comparison test: 
*P<0.05, **P<0.01 vs. controls; §§P<0.01, §§§P<0.001 vs. CreTrp1; ##P<0.01 vs. 
CreTrp1;Hif1af/f; xxP<0.01 vs. CreTrp1;Hif2af/f. Scale bars:  250µm (A); 500µm (B); 
























Fig. 3: Deletion of Hif2a causes delayed developmental angiogenesis. (A) iB4 
staining of whole retinal flatmounts (age: P6) shows a delayed vascular development 
in Hif2a KO lines in terms of radial expansion (B), vascularised area (C), number of 
branch points in the angiogenic front (D) and in the mature capillary bed (E). n=5-39. 
Also refer to Fig. S2A. In (D) and (E), whiskers are min and max value; line inside 
the box is the median. ANOVA and Tukey’s multiple comparison test: *P<0.05, 
***P<0.001 vs. controls; §§P<0.01, §§§P<0.001 vs. CreTrp1; #P<0.05, ###P<0.001 
vs. CreTrp1;Hif1af/f. Tip cells and filopodia (F-I) at the angiogenic front (highlighted - 
red dashed line) for all the genotypes analysed. n=6-19 (4 fields of view/eye). No 
significant differences (ANOVA). (J) Notch pathway gene expression assessed by 





















expressed as percentage of controls (normalised to endothelial marker Pecam-1 and 
housekeeping gene Actb); no significant differences (ANOVA). Each sample was a 
























Fig. 4: Vascular phenotype in Hif2a KO lines results in delayed plexi formation 
and fewer arteries and veins. (A) Time-course quantification of deep, intermediate 
and superficial plexi formation (% of controls). Refer to Fig. S3 for control plexi. n=5-
12 animals/genotype/time point. ANOVA and Bonferroni multiple comparison test 
performed vs. CreTrp1: $P<0.05, $$P<0.01 CreTrp1;Hif1af/f vs. CreTrp1; *P<0.05, 
**P<0.01, ***P<0.001, ****P<0.0001 CreTrp1;Hif2af/f vs. CreTrp1; #P<0.05, ##P<0.01, 





















of P9 CreTrp1;Hif2af/f vasculature. (C) Persistent hypoxia between the primary and the 
deep plexi (GCL and INL). (D) IB4 staining revealing reduction in arteries and veins 
in Hif2a KO lines. Quantification shown in (E). n=8-12. ANOVA and Tukey’s multiple 
comparison test: *P<0.05, **P<0.01, ***P<0.001 vs. controls; §§P<0.01, §§§P<0.001 
vs. CreTrp1; #P<0.05, ###P<0.001 vs. CreTrp1;Hif1af/f. Scale bars: 50µm (B, C), 
























Fig. 5: Hif2a KO lines show reduced endothelial cells division, a normal Vegfr2 
activation and increased endostatin levels. (A) EdU inclusion in endothelial cells 
nuclei (stained with Erg) at the angiogenic front (age: P6). Values are quantified in 
(B). n=5; 4 fields/animal quantified. ANOVA and Tukey’s multiple comparison test: 
**P<0.01, ***P<0.001 vs. controls; §§P<0.01, §§§P<0.001 vs. CreTrp1; ##P<0.01, 
###P<0.001 vs. CreTrp1;Hif1af/f. (C) Representative western blot of whole retina 
lysates (age: P5) probed for total Vegfr2, phosphorylated Vegfr2 (Y1145) and b-
tubulin. Densitometry reported in (D) and (E). Values expressed as percentage 





















vs. controls; §P<0.05 vs. CreTrp1. (F) Angiogenesis proteome profiler array of P6 
whole retina lysates (pooled n=10 retinae). Densitometry reported in (G). (H) 
Representative western blot of whole retina lysates (age: P6) probed for endostatin 
and b-actin. Densitometry reported in (I). Values expressed as percentage relative to 
controls; n=4-6 animals. ANOVA and Tukey’s multiple comparison test: *P<0.05 vs. 
























Fig. 6: Characterisation of neuroretina cells expressing Cre recombinase in 
CreTrp1 line. (A) Representative flow cytometry (P5 and young adult) of 
CreTrp1;ROSAmT/mG. (B) Quantification of total live GFP+ and GFP- cells. n=24-52 
animals/age. (C) RT-qPCR analysis of GFP+ cells FACS-sorted from P5 
CreTrp1;ROSAmT/mG. Targets analysed: Hif2a, Vegf and Epo. n=6-7. ANOVA and 
Tukey’s multiple comparison test: §§P<0.01, §§§§P<0.0001 vs. CreTrp1;ROSAmT/mG. 
(D) Quantification of GFP+ and GFP- cells for each sub-population analysed by flow 
cytometry on adult dissociated CreTrp1;ROSAmT/mG retinae. Please refer to Table S1-
S2 for markers and reference percentages. (E) The histogram compares the 
composition of the GFP+ sub-population to the composition of the whole retina of 
adult CreTrp1;ROSAmT/mG mice (values expressed as percentage of the total retina 
composition). n=5-9. PR: photoreceptors; MG: Müller glia; rBP: rod bipolar cells; AC: 
























Fig. 7: Cre expression affects late neuroprogenitors in the CreTrp1 line. (A) P1 
section from CreTrp1 line showing co-localisation of mGFP+ cells and ganglion 
cell/neuroprogenitor marker Pax6 (false-coloured in red for better visualisation). 
mTomato signal not shown. (A’) 3D reconstruction of (A). (B) Representative flow 
cytometry of P5 Pax6+/mGFP+ cells in P5 CreTrp1;ROSAmT/mG retina. (C) 
Quantification of GFP+ and GFP- Pax6+ cells. n=7 animals/age. (D) Representative 
flow cytometry of GFP+ cells in P5 CreTrp1;GFPRlbp1 retina. (E) RT-qPCR analysis of 
Cre copy number in GFP+ cells FACS-sorted from indicated genotypes (age: P5). 
Values are from n=5-14. (F) RT-qPCR analysis of Hif2a and downstream targets 
Vegf and Epo on FACS-sorted GFP+ cells (age: P5). Values are from n=4-5 samples 
and are normalized to GFP+ cells isolated from GFPRlbp1. ANOVA and Tukey’s 
multiple comparison test: *P<0.05, **P<0.01 vs. controls; §P<0.05, §§P<0.01, 





















same confocal z-stack) shows points of contact between GFP+ retinal 
neuroprogenitors’ projections and endothelial cells. Increased transparency helps 
appreciating the interactions (see red arrows). Similarly, late neuroprogenitors 
interact with mature capillary bed as shown in (I-J). Scale bar: 25µm (A, A’); 20µm 
























Fig. 8: Although affected by Cre mediated-excision, astrocytes invade the 
developing retina in a timely manner. (A) P5 section from CreTrp1;ROSAmT/mG line 
showing co-localisation between GFP+ cells and astrocyte marker Pdgfr-a (false-
coloured in red for better visualisation). mTomato signal not shown. (A’) 3D re-
construction of (A). (B) Z-stack projection of a P5 flat-mounted retina from 
CreTrp1;ROSAmT/mG mouse showing astrocyte marker Gfap (false coloured in red for 





















Representative flow cytometry of Pdgfr-a+/GFP+ cells in P5 CreTrp1;ROSAmT/mG 
dissociated retina. (D) Quantification of GFP+ and GFP- in Pdgfr-a+ cell population. 
n=13 animals. (E) RT-qPCR analysis of Cre copy number in GFP+ and GFP- FACS-
sorted Pdgfr-a+ cells from P5 CreTrp1;ROSAmT/mG. Values expressed as copy 
number/ng of retro-transcribed RNA (n=8). (F) RT-qPCR analysis of Hif2a and its 
targets Vegf and Epo on Pdgfr-a+/GFP+ cells FACS-sorted from P5 
CreTrp1;ROSAmT/mG and CreTrp1;Hif2af/f;ROSAmT/mG lines. Values are relative 
percentage of CreTrp1;ROSAmT/mG (n=4-5). ANOVA and Tukey’s multiple comparison 
test: §P<0.05, §§P<0.01 vs. CreTrp1;ROSAmT/mG. (G) Retinal whole-mounts (age: P3) 
stained with Pdgfr-a. Tissue edges are highlighted with a light blue line, angiogenic 
front with a yellow dashed line. (H) Quantification of astrocyte radial expansion. n=4-
6; 4 fields of view analysed/sample. No significant differences (ANOVA). Scale bars: 
























Fig. 9: Viral delivery of Cre recombinase to late neuroprogenitors in the Hif2af/f 
mice recapitulates the vascular phenotype observed in CreTrp1; Hif2af/f mice. (A) 
Representative image of a wild-type eye injected with AAV-Nestin.RFP. (B) 
Representative flow cytometry of RFP virus in GFPRlbp1 mice and (C) quantification of 
RFP/GFP co-labelling. n=6.  (D) Quantification of cell types by flow cytometry of 
AAV-Nestin.Cre-injected ROSAmT/mG retinae, harvested and dissociated at P18. PR: 





















stained retinal flatmounts injected with AAV-Nestin.Cre in one eye and AAV-Null in 
the contralateral eye (genotypes indicated). (F) Quantification of vascular 
development. n=7-20. (G) Quantification of branch points in the angiogenic front and 
in the mature capillary bed. Orange (angiogenic front) and yellow (capillary bed) 
boxes in (E) represent examples of fields used for quantification. Values are 
expressed with box plots (n=7-15) as in Fig. 2D,E. ANOVA and Bonferroni multiple 
comparison test (F,G): *P<0.05, **P<0.01 vs. Hif2af/f;ROSAmT/mG/AAV-Null; #P<0.05, 
###P<0.001 vs. ROSAmT/mG/AAV-Null; §P<0.05, §§P<0.01, §§§P<0.001 vs. 
ROSAmT/mG/AAV-Nestin.Cre. (H) Representative images of arteries and veins. (I) Big 
vessels quantification. n=7-20. Unpaired t-test: *P<0.05 vs. ROSAmT/mG/AAV-Null. (J) 
Representative western blot of whole retinae (age: P6) for endostatin and b-actin. 
AAV-Null-treated eye and AAV-Nestin.Cre-treated eye loaded side-by-side. 
Densitometry reported in (K). Values expressed as percentage relative to controls; 
n=11. ANOVA and Tukey’s multiple comparison test: *P<0.05 vs. AAV-Null treated 
























Fig. 10: Delivery of Hif2a cDNA to CreTrp1;Hif2af/f neuroprogenitors partially 
rescues the vascular phenotype. (A) Images of iB4-stained retinal flatmounts 
injected with AAV-Nestin.Hif2a and AAV-Null controlaterally (genotypes: Hif2af/f and 
CreTrp1;Hif2af/f). (B) Quantification of vascular development in terms of radial 
expansion and vascularised area. n=10-25. (C) Quantification of branch points in the 
angiogenic front and in the mature capillary bed. Orange (angiogenic front) and 





















quantification. Values are expressed with box plots (n=14-25) as in Fig. 2D,E. Two-
way ANOVA and Bonferroni multiple comparison test (the group upon which the 
symbol is placed vs. the group indicated in the following description): *P<0.05, 
***P<0.001 vs. Hif2af/f/AAV-Null; §§P<0.01, §§§P<0.001 vs. Hif2af/f/AAV-
Nestin.Hif2a; ##P<0.01, ###P<0.001 vs. CreTrp1; Hif2af/f/AAV-Null. (D) Arteries and 
veins in CreTrp1;Hif2af/f AAV-injected eyes. (E) Big vessels quantification. n=20-26. 
Unpaired t-test: *P<0.05 vs. AAV-Null. (F) RT-qPCR analysis of Hif2a copy number 
in GFP+ FACS-sorted cells from P6 CreTrp1;Hif2af/f;GFPRlbp1 virally injected retinae. 
Values are expressed as copy number/ng of retro-transcribed RNA (n=6). Unpaired 
t-test: *P<0.05 vs. Null-injected eyes. (G) EdU inclusion in endothelial nuclei (stained 
with Erg) at the angiogenic front (age: P6). Values are quantified in (H) and in (I); 
n=9-13; 4 fields/animal quantified. ANOVA and Tukey’s multiple comparison test: 
*P<0.05, ***P<0.001 vs. Hif2af/f/AAV-Null; §P<0.05 vs. CreTrp1;Hif2af/f/AAV-Null. (J) 
Representative western blot of whole retina lysates (age: P6) probed for endostatin 
and b-actin. Hif2af/f and CreTrp1;Hif2af/f loaded side-by-side are littermates. AAV-Null-
treated eye and AAV-Nestin.Hif2a-treated eye loaded side-by-side. Densitometry in 
(K). Values expressed as percentage of controls (n=8). ANOVA and Tukey’s multiple 
comparison test result: ***P<0.001 vs. Hif2af/f/AAV-Null eyes; §P<0.05 vs. 



































































































































































































































































































































































Marker(s) Cell target Abbreviation Reference
CD73 Photoreceptors PR Koso et al., 2009
Glutamine Synthetase Müller glia MG Grossman et al., 1994
Pkc-a Rod bipolar cells rBP Ruether et al., 2010
Calbindin Amacrine/ Horizontal cells AC/HC Liu et al., 2013
Pax6 Ganglion cells/retinal progenitor cells GC/RPC Hitchcock et al., 1996; Stanescu-Segall et al., 2015
PDGFR-a Astrocytes A Tao and Zhang, 2014
CD11b/CD45 Myeloid cells MC Liyanage et al., 2016
NG2 Pericytes P Ozerdem et al., 2001
Supplemental Table S1: Markers used by flow cytometry for cell type characterisation. 




 neuroretinae are listed and referenced. 



































Reference % from (Jeon et 
al., 1998; Macosko et al., 
2015)
Photoreceptors 82.4 81.3 82.1
Müller glia 1.17 1.82 2.80
Rod Bipolar cells 1.54 1.62 * 7.3
Amacrine/horizontals 0.024 0.020 7.00
Ganglion cells 0.45 0.48 0.50
Astrocytes 0.09 0.07 0.10
Myeloid cells 0.28 0.11 0.20
Pericytes 0.20 0.10 ND
Undetermined 13.82 14.49 7.30
Total 100.00 100.00 100.00
Supplemental Table S2: Comparison of cell type percentages to published values. 




 retina and GFP+ gated population) are compared to reference 
values reported in the literature (25, 26)
* Value relative to the entire bipolar cells population (as opposed to only rod bipolar cells, identified by PKCa in this study).     











































Supplier (catalogue number) Application Dilution Intracellular/extracellular (FC)
Arrestin 3 Rabbit Novus Biologicals (NBP1-19629) IF 1:200
Collagen IV Rabbit Bio-Rad (2150-1470) IF 1:200
Cre recombinase Mouse Millipore (MAB 3120) IF 1:100
ERG Rabbit Abcam (ab92513) IF 1:200
Fibronectin Rabbit Millipore (AB 2033) IF 1:200
GFAP Rabbit Dako (Z0334) IF 1:200
Hif2a Rabbit Novus Biologicals (NB100) IF 1:200
Iba1 Rabbit Alpha Labs (019-19741) IF 1:1000
Isolectin B4 (biotin-conjugated) N/A Sigma-Aldrich (L2140) IF 1:200
Neurofilament-L Rabbit Millipore (C28E10) IF 1:500
Beta-Actin Mouse R&D Systems (MAB8929) WB 1:5000
Beta-Tubulin Mouse Sigma-Aldrich (T4026) WB 1:1000
Endostatin Goat R&D Systems (AF570-SP) WB 1:1000
Total VEGFR2 Rabbit Cell Signalling (9698) WB 1:1000
VEGFR2 pY1175 Rabbit Cell Signalling (3770) WB 1:1000
Calbindin Mouse Abcam (ab75524) FC 1:50 Intracellular (fixed)
CD11b Rat (PerCP-Cy5) Biolegend (101227) FC 1:100 Extracellular (unfixed)
CD45 Rat (BUV-395) BD Biosciences (565967) FC 1:100 Extracellular (unfixed)
CD73 Rat (PE-Cy7) Thermo Fisher Scientific (25-0731-80) FC 1:100 Extracellular (unfixed)
Glutamine synthetase Mouse BD Biosciences (610517) IF/FC 1:200 (IF)/1:50 (FC) Intracellular (fixed)
Isolectin B4 (FITC-conjugated) N/A Vector Labs (FL-1201) FC 1:100 Extracellular (unfixed)
NG2 Chondroitin Sulfate 
Proteoglycan
Rabbit Millipore (AB 5320) IF/FC 1:200 (IF)/1:50 (FC) Intracellular (fixed)
Pax6 Rat (APC) Miltenyi Biotec (130-107-829) IF/FC 1:100 (IF)/1:50 (FC) Intracellular (fixed)
PDGFRa Rat (APC) Biolegend (APA5) IF/FC 1:100 (IF)/1:50 (FC) Extracellular (unfixed)
PKCa Rabbit Santa Cruz (H-7) IF/FC 1:200 (IF)/1:50 (FC) Intracellular (fixed)




Thermo Fisher Scientific (A21052; 
A21070; S21375)
IF/FC 1:500 (IF)/1:200 (FC)
Biotin-conjugated secondary 
antibodies
Goat Thermo Fisher Scientific (31430; 31460) WB 1:2000 - 1:5000
Biotin-conjugated secondary 
antibodies
Rabbit Dako (P0449) WB 1:2000
Supplemental Table S3: List of antibodies and conditions used.
List of antibodies, dilutions and fixation used for immunofluorescence (IF), western blotting (WB) and flow cytometry (FC). 





















Target gene Forward primer (5'-3') Reverse primer (5'-3') Probe (Roche Diagnostics)
Actb aaggccaaccgtgaaaagat gtggtacgaccagaggcatac 56
Cre caataccggagatcatgcaa cactatccaggttacggatatagttca 83
Dll1 aggggagctacacatgttcc gggctaggagcacactcatc 11
Dll4 tactgctgctggcggtact gctggttgacgaactcctg 11
Epo tctgcgacagtcgagttctg cttctgcacaacccatcgt 16
Hes1 tgccagctgatataatggagaa ccatgataggctttgatgacttt 83
Hey1 acgacatcgtcccaggttt actgttattgattcggtctcgtc 72
Hif1a tgagcttgctcatcagttgc cataacagaagctttatcaagatgtga 60
Hif2a tgacagctgacaaggagaaaaa caactcatagaagacctccgtctc 12
Notch 1 tggacgacaatcagaacgag cctcaaaccggaacttcttg 85
Notch 4 ccatccagctgatgactcct atccctgcaccagtgtcct 16
Pecam-1 cggtgttcagcgagatcc actcgacaggatggaaatcac 45
Vegf (all isoforms) actggaccctggctttactg tgggacttctgctctccttc 64
List of primers and probes (Roche Diagnostics, UK) used.
Supplemental Table S4: real-time quantitative PCR primers and probes.
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